Pinealon: Complete Research Guide & Chemical Profile

Pinealon is the research designation for the synthetic tripeptide L-glutamyl-L-aspartyl-L-arginine (Glu-Asp-Arg, single-letter code EDR). The molecular formula is C15H26N6O8 with a molecular weight of approximately 418.40 Da. The peptide contains three amino acid residues connected by two peptide bonds, with a free alpha-amino group on the N-terminal glutamic acid and a free alpha-carboxyl group on the C-terminal arginine. The molecule carries a net charge of -1 at physiological pH 7.4, with one positive charge from the arginine guanidinium group and two negative charges from the glutamic acid and aspartic acid side chain carboxylates.

As a tripeptide, Pinealon belongs to the class of ultrashort bioregulatory peptides developed from the concept of cytomedines -- tissue-specific peptide extracts that exert regulatory effects on the organs from which they were derived. The parent extract, Epithalamin, was isolated from bovine pineal glands and shown to contain multiple peptide fractions. Through systematic fractionation and activity-guided purification, the EDR tripeptide was identified as one of the minimal active sequences retaining pinealotropic activity from the complex mixture.

The small size of Pinealon places it below the conventional threshold for peptide receptor-ligand interactions, which typically require longer sequences for high-affinity binding. Instead, Khavinson and colleagues have proposed that ultrashort peptides (2-4 amino acids) exert their effects through direct interactions with DNA, specifically by binding to complementary nucleotide sequences in gene promoter regions. This epigenetic mechanism, while non-conventional, has been supported by molecular modeling, electrophoretic mobility shift assays, and gene expression studies from the Khavinson laboratory.

• Sequence: Glu-Asp-Arg (EDR)
• Molecular weight: ~418.40 Da
• Molecular formula: C15H26N6O8
• Net charge at pH 7.4: -1
• Parent extract: Epithalamin (bovine pineal gland extract)
• Classification: Khavinson bioregulator peptide / cytomedine
• Target organ: Pineal gland
• Appearance: White crystalline powder
• Solubility: Freely soluble in water

The bioregulation theory developed by Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology proposes that short peptides (2-4 amino acids) serve as natural epigenetic regulators that control gene expression in a tissue-specific manner. According to this framework, each tissue produces characteristic short peptides during normal protein turnover, and these peptides interact with specific DNA sequences in gene promoter regions to regulate transcription of genes essential for tissue-specific function and homeostasis.

The theoretical basis for peptide-DNA interaction relies on complementary structural recognition between amino acid side chains and nucleotide bases in the DNA major groove. Molecular modeling studies from the Khavinson group have proposed that specific di- and tripeptide sequences show selective binding to particular dinucleotide and trinucleotide sequences through hydrogen bonding and electrostatic interactions. For Pinealon (EDR), computational studies predict preferential binding to specific DNA sequences in regulatory regions of genes involved in pineal gland function and antioxidant defense.

The Khavinson bioregulation concept has generated substantial published research, primarily from Russian and Eastern European laboratories, with over 100 publications in indexed journals. The approach has produced a series of tissue-specific peptide bioregulators: Epithalon (AEDG, targeting the pineal gland and telomerase), Pinealon (EDR, targeting pineal gland and CNS), Cortagen (AEDP, targeting cerebral cortex), Vilon (KE, targeting immune system), and Livagen (EW, targeting liver). While the concept remains outside mainstream Western pharmacological frameworks, the body of preclinical data continues to accumulate.

The pineal gland is a small neuroendocrine organ located in the epithalamus that produces melatonin (N-acetyl-5-methoxytryptamine), the primary hormonal signal of darkness in the circadian timing system. Melatonin synthesis follows a circadian rhythm controlled by the suprachiasmatic nucleus (SCN) via a multisynaptic pathway through the superior cervical ganglia. The rate-limiting enzyme in melatonin synthesis is arylalkylamine N-acetyltransferase (AANAT), whose expression and activity show dramatic circadian variation with nighttime peaks 10-100 fold above daytime levels.

Research from the Khavinson laboratory has investigated the effects of Pinealon on melatonin synthesis in both in vitro and in vivo models. In cultured pinealocytes (pineal gland cells), Pinealon treatment increased melatonin production and upregulated expression of the genes encoding the melatonin synthesis enzymes AANAT and hydroxyindole-O-methyltransferase (HIOMT/ASMT). In aged rats, where pineal function and nocturnal melatonin peaks are diminished, Pinealon administration partially restored the amplitude of the nocturnal melatonin rhythm.

The proposed mechanism for melatonin modulation involves Pinealon interaction with regulatory DNA sequences in the AANAT gene promoter region, enhancing transcriptional activity. Additionally, Pinealon may protect pinealocytes from age-related functional decline by reducing oxidative damage and maintaining cellular viability. The pineal gland is particularly vulnerable to oxidative stress due to its high metabolic rate, rich blood supply, and the oxidative byproducts generated during melatonin synthesis itself. Pinealon antioxidant effects may therefore indirectly support melatonin production by preserving pinealocyte integrity.

Pinealon has demonstrated neuroprotective properties in several in vitro neurotoxicity models. In primary cortical neuron cultures exposed to oxidative stress (hydrogen peroxide), excitotoxicity (glutamate), and amyloid-beta peptide toxicity, Pinealon pre-treatment reduced neuronal death by 20-40% compared to untreated controls as assessed by MTT viability assay, LDH release, and TUNEL apoptosis staining. The protective effect was concentration-dependent, with optimal activity in the 10-100 nanomolar range.

The neuroprotective mechanisms identified in published studies include: (1) upregulation of anti-apoptotic protein Bcl-2 and downregulation of pro-apoptotic Bax, shifting the Bcl-2/Bax ratio toward cell survival; (2) reduction of caspase-3 and caspase-9 activation, inhibiting the mitochondrial apoptosis cascade; (3) preservation of mitochondrial membrane potential under stress conditions; and (4) reduction of reactive oxygen species (ROS) accumulation through enhanced expression of endogenous antioxidant enzymes including superoxide dismutase (SOD) and glutathione peroxidase (GPx).

In organotypic hippocampal slice cultures, a model that preserves three-dimensional neural architecture and synaptic connectivity, Pinealon reduced CA1 pyramidal neuron loss following oxygen-glucose deprivation (an in vitro ischemia model). The protective effect was associated with reduced expression of pro-inflammatory markers (iNOS, COX-2) in hippocampal microglia, suggesting an anti-neuroinflammatory component to the neuroprotective mechanism. These findings expand the activity profile of Pinealon beyond direct neuronal protection to include modulation of the neuroinflammatory environment.

Transcriptomic studies using microarray and qRT-PCR analysis have investigated the gene expression changes induced by Pinealon treatment in neural tissue and cell lines. In human neuroblastoma SH-SY5Y cells, Pinealon treatment (100 nM, 24-72 hours) differentially regulated approximately 60 genes, with significant enrichment in functional categories related to antioxidant defense, DNA repair, apoptosis regulation, and signal transduction. Key upregulated genes included SOD2 (manganese superoxide dismutase), HMOX1 (heme oxygenase 1), and BCL2 (B-cell lymphoma 2).

Of particular interest is the reported effect of Pinealon on the expression of the AANAT gene and other circadian clock-related genes. In pinealocyte cultures, Pinealon increased expression of AANAT, PER1, and BMAL1, suggesting modulation of the local molecular clock machinery in addition to the melatonin synthesis pathway. Whether these gene expression changes result from direct peptide-DNA interaction as proposed by the Khavinson theory or from indirect signaling cascade activation remains an active area of investigation.

Electrophoretic mobility shift assay (EMSA) experiments published by the Khavinson group reported that the EDR tripeptide binds to specific double-stranded DNA oligonucleotides containing the trinucleotide sequences GAT and GAC. The proposed binding involves the glutamic acid and aspartic acid side chains interacting with complementary nucleotide bases through hydrogen bonding. However, independent replication of these peptide-DNA binding studies by other research groups is limited, and the specificity and affinity of such interactions relative to other DNA-binding mechanisms require further characterization.

The antioxidant properties of Pinealon have been characterized in both cell-free and cell-based assay systems. In cell-free radical scavenging assays (DPPH, ABTS, ORAC), Pinealon shows modest direct radical scavenging activity attributable to the electron-donating properties of the glutamic acid and arginine side chains. However, the direct antioxidant capacity of the tripeptide is substantially lower than established antioxidants like glutathione or vitamin C, suggesting that indirect mechanisms (enzyme induction) are more relevant to its cellular antioxidant effects.

The primary antioxidant mechanism appears to involve upregulation of the Nrf2 (nuclear factor erythroid 2-related factor 2) transcriptional pathway, the master regulator of the cellular antioxidant response. Pinealon treatment has been reported to increase nuclear translocation of Nrf2 and subsequent transcription of antioxidant response element (ARE)-dependent genes including NQO1, GCLC, GCLM (glutathione synthesis enzymes), and HMOX1. This indirect antioxidant amplification provides sustained protection that exceeds what the peptide itself could achieve through direct radical scavenging.

Cytoprotective effects beyond antioxidant defense have been documented. Pinealon treatment reduced UVB-induced DNA damage (cyclobutane pyrimidine dimers and 8-oxo-deoxyguanosine) in keratinocyte cultures, associated with enhanced nucleotide excision repair (NER) pathway activity. In cardiomyocyte cultures subjected to simulated ischemia-reperfusion, Pinealon reduced cell death and preserved contractile function. These diverse cytoprotective observations across cell types suggest activation of conserved cellular stress response pathways rather than tissue-specific receptor-mediated mechanisms.

Pinealon has been investigated as a potential geroprotective agent based on the broader Khavinson hypothesis that age-related functional decline is partly driven by progressive loss of peptide bioregulators and consequent dysregulation of tissue-specific gene expression. The pineal gland undergoes significant age-related changes including calcification, reduced melatonin production, and diminished nocturnal melatonin peak amplitude, which are associated with circadian rhythm disruption, impaired antioxidant defense, and immune dysregulation in aging organisms.

In aging rodent models (18-24 month old rats and mice), chronic Pinealon administration (2-4 weeks) was reported to partially restore nocturnal melatonin levels, improve antioxidant enzyme activity in brain tissue, reduce lipid peroxidation products (malondialdehyde, 4-hydroxynonenal), and improve performance on spatial learning and memory tasks (Morris water maze, passive avoidance). These effects were attributed to restoration of pineal function and secondary benefits of improved melatonin signaling on CNS antioxidant defense and neuroplasticity.

Long-term geroprotection studies using the parent extract Epithalamin (from which Pinealon was derived) reported increased mean and maximum lifespan in several rodent cohorts, along with reduced spontaneous tumor incidence. Whether synthetic Pinealon alone reproduces the full geroprotective effects of the complex Epithalamin extract remains to be definitively established. The lifespan extension reported with Epithalamin has been attributed to the combined effects of melatonin restoration, antioxidant enhancement, immunomodulation, and potentially telomerase regulation (the latter being more closely associated with Epithalon/AEDG, a related tetrapeptide).

Analytical characterization of Pinealon utilizes standard peptide chemistry methods adapted for the small size of the tripeptide. RP-HPLC on C18 columns with aqueous TFA/acetonitrile gradient elution provides identity and purity assessment. Due to the hydrophilic nature of the EDR tripeptide (three charged side chains), the peptide elutes early in the gradient (typically 5-12% acetonitrile), requiring ion-pairing reagents (TFA) for adequate retention. Purity specifications for research-grade material typically require greater than 95% by HPLC.

Mass spectrometric identity confirmation by ESI-MS shows the expected [M+H]+ ion at m/z 419.18 and [M+2H]2+ at m/z 210.10. The small size of the tripeptide limits the informational content of MS/MS fragmentation, but characteristic b2 (Glu-Asp, m/z 247.07) and y2 (Asp-Arg, m/z 290.12) ions provide sequence confirmation. For quantitative determination in biological matrices, LC-MS/MS with stable isotope-labeled internal standard ([13C,15N]-EDR) provides the required sensitivity and selectivity with limits of quantification in the low ng/mL range.

Amino acid analysis after acid hydrolysis (6N HCl, 110C, 22 hours) confirms the expected equimolar ratio of glutamic acid, aspartic acid, and arginine. The free acid forms of Glu and Asp are quantified without distinguishing them from their amide forms (Gln, Asn), as the amide bonds are hydrolyzed during sample preparation. Capillary electrophoresis (CE) with UV detection at 200 nm provides an orthogonal separation method to HPLC, exploiting the charge properties of the tripeptide for separation based on electrophoretic mobility.

Pinealon demonstrates good stability as a lyophilized powder when stored at -20°C under desiccated conditions, with no significant degradation observed over 24 months. The primary degradation pathways in solution include peptide bond hydrolysis (cleavage between Glu-Asp or Asp-Arg), aspartimide formation at the Asp residue (intramolecular cyclization), and deamidation if Asn is present in any impurity context. In aqueous solution at pH 7.4 and 25°C, the half-life is approximately 2-4 weeks, with degradation accelerated at elevated temperatures and extreme pH values.

For research applications, stock solutions (1-10 mM) should be prepared in sterile water, phosphate-buffered saline, or physiological saline. The tripeptide is freely soluble in aqueous media with no surfactant or co-solvent requirement. Stock solutions should be aliquoted into single-use volumes, flash-frozen in liquid nitrogen, and stored at -80°C. Stability in cell culture media (DMEM, RPMI) at 37°C is limited to approximately 24-48 hours due to peptidase activity in serum-containing media; serum-free or low-serum conditions extend stability.

Typical research concentrations for cell culture studies range from 1 nM to 10 micromolar, with most published studies reporting optimal effects in the 10-100 nM range. For in vivo rodent studies, published protocols use intraperitoneal or subcutaneous injection at doses of 0.1-10 micrograms per kilogram body weight, often administered daily for 5-14 consecutive days. The short in vivo half-life (estimated at minutes for a small unprotected peptide) necessitates repeated dosing for sustained effects, though the proposed epigenetic mechanism suggests that brief exposure may be sufficient to trigger lasting gene expression changes.

The following publications represent key research on Pinealon and the Khavinson bioregulatory peptide framework. Researchers are directed to these primary sources for experimental protocols and detailed data.

• Read more: TRH (Thyrotropin-Releasing Hormone): Research Guide & Chemical Profile → https://www.chemverify.com/learn/trh-thyrotropin-releasing-hormone-research-guide
• Read more: Ipamorelin + CJC-1295 (No DAC) Stack: Synergy Research Guide → https://www.chemverify.com/learn/ipamorelin-cjc-1295-no-dac-stack-synergy
• Read more: Epithalon: Complete Research Guide & Chemical Profile → https://www.chemverify.com/learn/epithalon
• Read more: Semax for Cognitive Research: ACTH(4-10) Analog Mechanism → https://www.chemverify.com/learn/semax-cognitive-research-acth-mechanism